Business
GB Sciences, Inc. Announces The Appointment Of Mr. Leslie Bocskor As Vice Chairman
GB Sciences, Inc. Announces The Appointment Of Mr. Leslie Bocskor As Vice Chairman.
About this update from Gb Sciences, Inc.
[{"type":"text","content":"\n\n\n\nGB Sciences, Inc. Announces The Appointment Of Mr. Leslie Bocskor As Vice Chairman\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nGB Sciences, Inc. Announces The Appointment Of Mr. Leslie Bocskor As Vice Chairman\nPR Newswire\nLAS VEGAS, May 22, 2017\n\n\n\nLAS VEGAS, May 22, 2017 /PRNewswire/ -- GB Sciences, Inc. (OTCQB:GBLX) is pleased to announce the appointment of Mr. Leslie Bocskor as Vice Chairman, effective April 28, 2017.  John Poss remains Chairman of the Board and CEO.\n\n\n \n \n\n \nBocskor has been a director of GB Sciences (\"the Company\") since May 2016, and in this role has been instrumental in the Company's capital formation process and in the Company's relationship with its investment bank, Network 1.  Network 1 has raised over $14 million to fund GB Sciences' further growth and investments.  Bocskor also brought Shane Terry to the Board of Directors.  Mr. Terry is an independent consultant who provides advisory services to Medical Marijuana Establishments (MME's) in Nevada and other states.  With Bocskor's focus on shareholder value in building a biopharma and life sciences powerhouse with strong IP, innovative research programs, and technology, he brings a broad understanding of the future of cannabis markets, investment banking, and cannabis policy.\n\n\"Leslie's leadership and vision within our industry has been invaluable in helping us stay ahead of the changes in the industry and to properly leverage the assets of our Life Sciences Division throughout the value chain,\" said John Poss, GB Sciences CEO and Chairman of the Board.\n\n\"I'm honored to be in a role where I can serve industry and science by changing people's lives and by changing the way in which cannabis innovation in medicine is brought to market.  I'm incredibly encouraged by the strides that we have already made with GB Sciences in advancing the state of biomedical research in cannabis for human health. I look forward to contributing more guidance for continued success,\" stated Bocskor.\n\nAbout GB Sciences, Inc.GB Sciences, Inc. (GBLX) ...